These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 12367730

  • 1. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase.
    Sehr P, Müller M, Höpfl R, Widschwendter A, Pawlita M.
    J Virol Methods; 2002 Oct; 106(1):61-70. PubMed ID: 12367730
    [Abstract] [Full Text] [Related]

  • 2. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology.
    Sehr P, Zumbach K, Pawlita M.
    J Immunol Methods; 2001 Jul 01; 253(1-2):153-62. PubMed ID: 11384677
    [Abstract] [Full Text] [Related]

  • 3. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
    Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT.
    J Natl Cancer Inst; 1994 Apr 06; 86(7):494-9. PubMed ID: 8133532
    [Abstract] [Full Text] [Related]

  • 4. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.
    Hassan SW, Waheed MT, Müller M, Clarke JL, Shinwari ZK, Lössl AG.
    Hum Vaccin Immunother; 2014 Apr 06; 10(10):2975-82. PubMed ID: 25483463
    [Abstract] [Full Text] [Related]

  • 5. VLP Production from Recombinant L1/L2 HPV-16 Protein Expressed in Pichia Pastoris.
    Sanchooli A, Aghaiypour K, Kiasari BA, Samarbaf-Zadeh A, Ghadiri A, Makvandi M.
    Protein Pept Lett; 2018 Apr 06; 25(8):783-790. PubMed ID: 30091403
    [Abstract] [Full Text] [Related]

  • 6. Comparison of a VLP-based and GST-L1-based multiplex immunoassay to detect vaccine-induced HPV-specific antibodies in first-void urine.
    Pattyn J, Panicker G, Willhauck-Fleckenstein M, Van Keer S, Téblick L, Pieters Z, Tjalma WAA, Matheeussen V, Van Damme P, Waterboer T, Unger ER, Vorsters A.
    J Med Virol; 2020 Dec 06; 92(12):3774-3783. PubMed ID: 32266996
    [Abstract] [Full Text] [Related]

  • 7. Detection of antibodies to L1, L2, and E4 proteins of human papillomavirus types 6, 11, and 16 by ELISA using synthetic peptides.
    Le Cann P, Chabaud M, Leboulleux D, Mougin C, Mayelo V, Legrand MC, Calvet C, Afoutou JM, Coll-Seck AM, Coursaget P.
    J Med Virol; 1995 Apr 06; 45(4):410-4. PubMed ID: 7545211
    [Abstract] [Full Text] [Related]

  • 8. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.
    Touze A, El Mehdaoui S, Sizaret PY, Mougin C, Muñoz N, Coursaget P.
    J Clin Microbiol; 1998 Jul 06; 36(7):2046-51. PubMed ID: 9650960
    [Abstract] [Full Text] [Related]

  • 9. Human papillomavirus (HPV) L1 and L1-L2 virus-like particle-based multiplex assays for measurement of HPV virion antibodies.
    Hernandez BY, Ton T, Shvetsov YB, Goodman MT, Zhu X.
    Clin Vaccine Immunol; 2012 Sep 06; 19(9):1348-52. PubMed ID: 22761294
    [Abstract] [Full Text] [Related]

  • 10. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins.
    Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M.
    Clin Chem; 2005 Oct 06; 51(10):1845-53. PubMed ID: 16099939
    [Abstract] [Full Text] [Related]

  • 11. Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention.
    Wakabayashi MT, Da Silva DM, Potkul RK, Kast WM.
    Intervirology; 2002 Oct 06; 45(4-6):300-7. PubMed ID: 12566713
    [Abstract] [Full Text] [Related]

  • 12. A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.
    Monroy-García A, Gómez-Lim MA, Weiss-Steider B, la Rosa GP, Hernández-Montes J, Pérez-Saldaña K, Tapia-Guerrero YS, Toledo-Guzmán ME, Santiago-Osorio E, Sanchez-Peña HI, Mora-García Mde L.
    Virol J; 2011 Feb 09; 8():59. PubMed ID: 21306638
    [Abstract] [Full Text] [Related]

  • 13. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    Trevisan A, Candeias JMG, Thomann P, Villa LL, Franco EL, Trottier H, The Ludwig-McGill Study Group.
    J Med Microbiol; 2020 Jul 09; 69(7):960-970. PubMed ID: 32510304
    [Abstract] [Full Text] [Related]

  • 14. Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus.
    Le Cann P, Touze A, Enogat N, Leboulleux D, Mougin C, Legrand MC, Calvet C, Afoutou JM, Coursaget P.
    J Clin Microbiol; 1995 May 09; 33(5):1380-2. PubMed ID: 7615761
    [Abstract] [Full Text] [Related]

  • 15. Immunization with a pentameric L1 fusion protein protects against papillomavirus infection.
    Yuan H, Estes PA, Chen Y, Newsome J, Olcese VA, Garcea RL, Schlegel R.
    J Virol; 2001 Sep 09; 75(17):7848-53. PubMed ID: 11483728
    [Abstract] [Full Text] [Related]

  • 16. [Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].
    Heim K, Christensen ND, Höpfl R, Wartusch B, Zeimet A, Larcher C, Ruth N, Bergant A, Pirschner G, Dierich MP.
    Gynakol Geburtshilfliche Rundsch; 1995 Sep 09; 35 Suppl 1():25-31. PubMed ID: 8672922
    [Abstract] [Full Text] [Related]

  • 17. Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.
    Robbins HA, Li Y, Porras C, Pawlita M, Ghosh A, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Gonzalez P, Schiller J, Lowy D, Esser M, Matys K, Quint W, van Doorn LJ, Herrero R, Pinto LA, Hildesheim A, Waterboer T, Safaeian M.
    BMC Infect Dis; 2014 Mar 03; 14():120. PubMed ID: 24588945
    [Abstract] [Full Text] [Related]

  • 18. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
    Varsani A, Williamson AL, de Villiers D, Becker I, Christensen ND, Rybicki EP.
    J Virol; 2003 Aug 03; 77(15):8386-93. PubMed ID: 12857908
    [Abstract] [Full Text] [Related]

  • 19. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
    Park JS, Oh YK, Kang MJ, Kim CK.
    J Med Virol; 2003 Aug 03; 70(4):633-41. PubMed ID: 12794729
    [Abstract] [Full Text] [Related]

  • 20. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
    Baek JO, Seo JW, Kwon O, Park SM, Kim CH, Kim IH.
    Enzyme Microb Technol; 2012 Mar 10; 50(3):173-80. PubMed ID: 22305172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.